COEP Coeptis posts narrower Q3 2024 loss than analyst estimates shares rise slightly on upbeat investor sentiment RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss ARMOUR REIT ARR Stock Intrinsic Value Review ARMOUR REIT Posts 93 EPS Miss On Rate Headwinds